BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38357950)

  • 1. The Use of Lipid-Based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments.
    Tantray J; Patel A; Prajapati BG; Kosey S; Bhattacharya S
    Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38357950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.
    Oliveira MS; Goulart GCA; Ferreira LAM; Carneiro G
    Expert Opin Drug Deliv; 2017 Aug; 14(8):983-995. PubMed ID: 27892713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells.
    Fatima Qizilbash F; Sartaj A; Qamar Z; Kumar S; Imran M; Mohammed Y; Ali J; Baboota S; Ali A
    J Drug Target; 2023 Sep; 31(8):794-816. PubMed ID: 37525966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm.
    Beigi A; Naghib SM; Matini A; Tajabadi M; Mozafari MR
    Curr Gene Ther; 2024 May; ():. PubMed ID: 38778601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
    Sala M; Diab R; Elaissari A; Fessi H
    Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
    Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
    Yang M; Gu Y; Tang X; Wang T; Liu J
    Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs.
    Sabit H; Abdel-Hakeem M; Shoala T; Abdel-Ghany S; Abdel-Latif MM; Almulhim J; Mansy M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes.
    Khan S; Sharma A; Jain V
    Adv Pharm Bull; 2023 Jul; 13(3):446-460. PubMed ID: 37646052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review.
    Buya AB; Witika BA; Bapolisi AM; Mwila C; Mukubwa GK; Memvanga PB; Makoni PA; Nkanga CI
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for preparation of nanostructured lipid carriers.
    Gomaa E; Fathi HA; Eissa NG; Elsabahy M
    Methods; 2022 Mar; 199():3-8. PubMed ID: 33992771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery.
    Priya S; Desai VM; Singhvi G
    ACS Omega; 2023 Jan; 8(1):74-86. PubMed ID: 36643539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.
    Valetti S; Mura S; Stella B; Couvreur P
    J Nanobiotechnology; 2013; 11 Suppl 1(Suppl 1):S6. PubMed ID: 24564841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.